As a pay-for-delay case continues in the nation’s Supreme Court, a lobby for independent drugstores is reportedly seeking widespread exemptions from antitrust laws that would allow the drugstores to charge higher prices for prescription drugs. The Pharmaceutical Care Management Association announced the news last Friday. Those lobby has sought the exemptions, which would affect consumers, employees, unions and government agencies, in the past. A recent government report found 80 percent of independent drugstores hire Pharmacy Service Administrative Organizations to do contract negotiations for them. The PMCA is voicing its opposition to the lobby’s requests arguing that they are asking for permission to fix prices and will lead in dramatic price hikes.
Featured News
Homebuyers’ Antitrust Case Against Top Brokerages Survives Key Court Challenge
Mar 30, 2026 by
CPI
KFTC Probes Paint Industry Over Suspected Price-Fixing Amid Cost Surge
Mar 30, 2026 by
CPI
Sysco to Acquire Jetro Restaurant Depot in $29 Billion Deal
Mar 30, 2026 by
CPI
Australia’s ACCC Faces Pressure to Approve Fuel Collaboration Among Miners
Mar 30, 2026 by
CPI
UK Regulator Launches Probe Into Major Firms Over Suspected Fake Reviews
Mar 30, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Competitor Collaborations
Mar 26, 2026 by
CPI
Between Scylla and Charybdis – Navigating Transatlantic Antitrust Currents
Mar 26, 2026 by
Tilman Kuhn & Niklas Brüggemann
Cartel Enforcement Moves Into the Labor Market: Trends and Implications
Mar 26, 2026 by
Andreas Kafetzopoulos & Caroline Janssens
Rethinking Buy-Side Antitrust “Group Boycotts”
Mar 26, 2026 by
Craig Falls & Brendan McGuire
Positive Collaborations: The Tools Available to Competition Authorities to Encourage Beneficial Interactions Between Competitors
Mar 26, 2026 by
Rona Bar-Isaac & Thomas Withers